Posted On: 12/11/2012 8:57:05 AM
Post# of 72433
![Avatar](https://investorshangout.com/images/ProfileImages/1012400077_3040_charlieb.jpg)
Re: ffaxedreceipts #3764
Agreed, and a "buyout" is something that may not come for years. A licensing agreement for Kevetrin ($5 billion annual potential) and Prurisol ($500 million-$1 billion annually) is a nice cash-cow for LEO and Dr Menon to oversee until they get "overwhelmed" with a buyout offer. Dr Menon is chiefly a scientist, and he wants to keep working on his other compounds...there is no rush on a buyout . . . which will make CTIX even that more valuable!
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)